Direkt zum Inhalt
Merck

C213630

DMT-2′O-TC-rC(ac) Phosphoramidite

configured for ABI

Synonym(e):

N4-Acetyl-O5′-(4,4′-dimethoxytrityl)-O2′-(1,1-dioxothiomorpholine-4-thiocarbonyl)cytidine O3′-(O-(2-cyanoethyl)-N,N-diisopropylphosphoramidite)

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

1 G

€ 354,00

€ 354,00


Warenkorb auf Verfügbarkeit prüfen

Großbestellung anfragen

Über diesen Artikel

Empirische Formel (Hill-System):
C46H57N6O11PS2
CAS-Nummer:
Molekulargewicht:
965.08
NACRES:
NA.51
PubChem Substance ID:
UNSPSC Code:
41116105
MDL number:
Assay:
≥98% (31P-NMR), ≥98.0% (reversed phase HPLC)
Form:
solid
Solubility:
acetonitrile: toluene (1:1): 0.1 M at 18 °C, clear
Storage temp.:
−20°C

Fortfahren mit

Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhalten

InChI

1S/C46H57N6O11PS2/c1-31(2)52(32(3)4)64(60-27-11-23-47)63-41-39(30-59-46(34-12-9-8-10-13-34,35-14-18-37(57-6)19-15-35)36-16-20-38(58-7)21-17-36)61-43(51-24-22-40(48-33(5)53)49-44(51)54)42(41)62-45(65)50-25-28-66(55,56)29-26-50/h8-10,12-22,24,31-32,39,41-43H,11,25-30H2,1-7H3,(H,48,49,53,54)/t39-,41-,42-,43-,64?/m1/s1

SMILES string

COc1ccc(cc1)C(OC[C@H]2O[C@H]([C@H](OC(=S)N3CCS(=O)(=O)CC3)[C@@H]2OP(OCCC#N)N(C(C)C)C(C)C)N4C=CC(NC(C)=O)=NC4=O)(c5ccccc5)c6ccc(OC)cc6

InChI key

OUGOPIOQANCAOY-JFALYFJISA-N

product line

Proligo Reagents

assay

≥98% (31P-NMR), ≥98.0% (reversed phase HPLC)

form

solid

mol wt

965.08 g/mol

technique(s)

oligo synthesis: suitable

impurities

≤0.3 wt. % water content (Karl Fischer), ≤0.5% 3′-TC isomer (reversed phase HPLC), ≤0.5% P(III) Impurities 145-155ppm (31P-NMR)

color

white to light yellow

solubility

acetonitrile: toluene (1:1): 0.1 M at 18 °C, clear

λ

conforms (UV/VIS Identity)

compatibility

configured for ABI

nucleoside profile

base: cytidine
base protecting group: acetyl
2' protecting group: TC
5' protecting group: DMT
deprotection: fast

storage temp.

−20°C

Quality Level

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 4

Dieser Artikel
G211600U211600U211630
Quality Level

200

Quality Level

200

Quality Level

200

Quality Level

200

form

solid

form

solid

form

solid

form

solid

assay

≥98% (31P-NMR), ≥98.0% (reversed phase HPLC)

assay

≥98% (31P-NMR), ≥98.0% (reversed phase HPLC)

assay

≥98% (31P-NMR), ≥98.0% (reversed phase HPLC)

assay

≥98% (31P-NMR), ≥98.0% (reversed phase HPLC)

solubility

acetonitrile: toluene (1:1): 0.1 M at 18 °C, clear

solubility

acetonitrile: toluene (1:1): 0.1 M at 18 °C, clear (for 72h)

solubility

acetonitrile: toluene (1:1): 0.1 M at 18 °C, clear (for 72h)

solubility

acetonitrile: toluene (1:1): 0.1 M at 18 °C, clear

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

color

white to light yellow

color

white to light yellow

color

white to light yellow

color

white to light yellow

General description

DMT-2′O-TC-rC(ac) Phosphoramidite belongs to TC RNA Phosphoramidites. These highly regarded, innovative monomers allow faster and more efficient RNA-based oligonucleotide manufacturing and the potential to build longer RNA oligonucleotides (>100 bases). TC RNA Phosphoramidites streamline the deprotection process resulting in consistently high-quality products, offering time and cost savings.

Features and Benefits

  • Reduced coupling times
  • Improved coupling efficiency
  • Single-step downstream process with neat Ethylenediamine (EDA)
  • Cleavage and deprotection within two hours at ambient temperature
  • Desalting of oligos not required
  • Allows for manufacturing of long RNA oligomers
  • High yields of final oligonucleotides
  • Next-day RNA oligo delivery

Legal Information

For use with Customer Container sold to end user customers either directly or through distributors.

This product is manufactured and sold under a license from Agilent Technologies under under US Patent No. 8,202,983 and pending U.S. Patent App. Nos. 13/485,5925, 13/531,191, and 13/339,082 and corresponding foreign counterparts, including those issuing from PCT/US08/63342 and PCT/US09/057922 all assigned to Agilent Technologies. The purchase of this product conveys to the buyer the limited, non-exclusive, non-transferable right (without the right to resell, repackage, or further sublicense) under these patents to use the product to synthesize Oligonucleotides for buyer′s internal research use only, including commercial purposes. Except as otherwise provided herein, no other license is granted to the buyer weather expressly, by implication, by estoppel or otherwise. Buyer agrees and understands that it is not licensed to use this product to synthesize Oligonucleotides for sale, for diagnostic uses including use in clinical diagnostic settings where the use in conjunction with an individual′s sample generates data provided to an individual or the individual′s caregiver for a free reimbursement, neither can Oligonucleotides synthesized using this product be used for use clinical trials or for other therapeutic purposes. This product is sold pursuant to authorization from Agilent Technologies, Inc. and Agilent Technologies reserves all other rights under these patents.

For use with all sales where the purchaser is required to have its own direct license from Agilent, without limitation, Bulk Quantity Sales, and sales to Oligo Houses.

This product and it uses are covered by under US Patent No. 8,202,983 and pending U.S. Patent App. Nos. 13/485,5925, 13/531,191, and 13/339,082 and corresponding foreign counterparts, including those issuing from PCT/US08/63342 and PCT/US09/057922 all assigned to Agilent Technologies. This product is sold to purchaser pursuant to authorization by Agilent Technologies, Inc. without any rights conferred by seller, based on purchaser′s direct license and authorization to purchase from Agilent Technologies, Inc. No license is granted to the purchaser weather expressly, by implication, by estoppel or otherwise on account of this purchase. Purchase′s rights to use this product are governed solely and expressly by purchaser′s direct license agreement with Agilent.
These products are manufactured and sold under a license from Agilent Technologies under US Patent No. 8,202,983 and pending U.S. Patent App. Nos. 13/485/5925, 13/531,191, and 13/339,082 and corresponding foreign counterparts, including those issuing from PCT/US08/63342 and PCT/US09/057922 all assigned to Agilent Technologies.

These products and its uses are covered by US Patent No. 8,202,983 and pending U.S. Patent App. Nos. 13/485/5925, 13/531,191, and 13/339,082 and corresponding foreign counterparts, including those issuing from PCT/US08/63342 and PCT/US09/057922 all assigned to Agilent Technologies.

Lagerklasse

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Verwandter Inhalt

TC RNA Phosphoramite User Guide

TC RNA Phosphoramidites Properties and Applications

TC RNA Oligonucleotides Synthesis and Application

TC RNA Phosphoramidites Product Information

Questions

Reviews

No rating value

Active Filters

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung